Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration
Terpos, E., Katodritou, E., Tsiftsakis, E., Kastritis, E., Christoulas, D., Pouli, A., Michalis, E., Verrou, E., Anargyrou, K., Tsionos, K., Dimopoulos, M. A., Zervas, K.Volume:
94
Language:
english
Journal:
Haematologica
DOI:
10.3324/haematol.2008.000638
Date:
March, 2009
File:
PDF, 437 KB
english, 2009